期刊文献+

Network-based method to infer the contributions of proteins to the etiology of drug side effects 被引量:3

Network-based method to infer the contributions of proteins to the etiology of drug side effects
原文传递
导出
摘要 Studying the molecular mechanisms that underlie the relationship between drugs and the side effects they produce is critical for drug discovery and drug development. Currently, however, computational methods are still unavailable to assess drug-protein interactions with the aim of globally inferring the contributions of various classes of proteins toward the etiology of side effects. In this work, we integrated data reflecting drug-side effect relationships, drug- target relationships, and protein-protein interactions to develop a novel network-based probabilistic model, SidePro, to evaluate the contributions of proteins toward the etiology of side effects. For a given side effect, the method applies an expectation--maximization algorithm and a diffusion kernel-based approach to estimate each protein's contribution. We applied this method to a wide range of side effects and validated the results using cross-validation and records from the Side Effect Resource database. We also studied a specific side effect, nephrotoxicity, which is known to be associated with the irrational use of the Chinese herbal compound triptolide, a diterpenoid epoxide in the Thunder of God Vine, Tripterygium wilfordii (Lei-Gong-Teng). Using triptolide as an example, we scored the target proteins of triptolide using our model and investigated the high-scoring proteins and their related biological processes. The results demonstrated that our model could differentiate between the potential side effect targets and therapeutic targets of triptolide. Overall, the proposed model could accurately pinpoint the molecular mechanisms of drug side effects, thus making contribution to safe and effective drug development. Studying the molecular mechanisms that underlie the relationship between drugs and the side effects they produce is critical for drug discovery and drug development. Currently, however, computational methods are still unavailable to assess drug-protein interactions with the aim of globally inferring the contributions of various classes of proteins toward the etiology of side effects. In this work, we integrated data reflecting drug-side effect relationships, drug- target relationships, and protein-protein interactions to develop a novel network-based probabilistic model, SidePro, to evaluate the contributions of proteins toward the etiology of side effects. For a given side effect, the method applies an expectation--maximization algorithm and a diffusion kernel-based approach to estimate each protein's contribution. We applied this method to a wide range of side effects and validated the results using cross-validation and records from the Side Effect Resource database. We also studied a specific side effect, nephrotoxicity, which is known to be associated with the irrational use of the Chinese herbal compound triptolide, a diterpenoid epoxide in the Thunder of God Vine, Tripterygium wilfordii (Lei-Gong-Teng). Using triptolide as an example, we scored the target proteins of triptolide using our model and investigated the high-scoring proteins and their related biological processes. The results demonstrated that our model could differentiate between the potential side effect targets and therapeutic targets of triptolide. Overall, the proposed model could accurately pinpoint the molecular mechanisms of drug side effects, thus making contribution to safe and effective drug development.
出处 《Frontiers of Electrical and Electronic Engineering in China》 CSCD 2015年第3期124-134,共11页 中国电气与电子工程前沿(英文版)
基金 This work is supported by National Natural Science Foundation of China (Nos. 81225025 and 91229201), and Tsinghua National Laboratory of Information Science and Technology (TNLIST) Big Data Grant.
关键词 network pharmacology drug targets side effects TRIPTOLIDE network pharmacology drug targets side effects triptolide
  • 相关文献

参考文献45

  • 1Scheiber, J., Chen, B., Milik, M., Sukuru, S. C. K., Bender, A., Mikhailov, D., Whitebread, S., Hamon, J., Azzaoui, K., Urban, L., et al. (2009) Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis. J. Chern. Inf. Model, 49, 308-317. 被引量:1
  • 2Berger, S. I. and Iyengar, R. (20 II) Role of systems pharmacology in understanding drug adverse events. Wiley Interdiscip. Rev. Syst. Biol. Med., 3, 129-135. 被引量:1
  • 3Roses, A. D. (2004) Pharmacogenetics and drug development: the path to safer and more effective drugs. Nat. Rev. Genet., 5, 645-656. 被引量:1
  • 4Stevens, J. L. and Baker, T. K. (2009) The future of drug safety testing: expanding the view and narrowing the focus. Drug Discov. Today, 14, 162-167. 被引量:1
  • 5Shah, R. R. (2006) Can pharmacogenetics help rescue drugs withdrawn from the market? Pharmacogenomics, 7, 889-908. 被引量:1
  • 6Zhang, W, Roederer, M. W., Chen, W-Q., Fan, L. and Zhou, H.-H. (2012) Pharmacogenetics of drugs withdrawn from the market.Pharmacogenornics, 13,223-231. 被引量:1
  • 7Liebler, D. C. and Gucngerich, F. P. (2005) Elucidating mechanisms of drug-induced toxicity. Nat. Rev. Drug Discov., 4, 410-420. 被引量:1
  • 8u, R., Ma, T., Gu, J., Liang, X. and u, S. (2013) Imbalanced network biomarkers for traditional Chinese medicine Syndrome in gastritis patients. Sci. Rep., 3, 1543. 被引量:1
  • 9Zhao, S. and u, S. (2010) Network-based relating pharmacological and genomic spaces for drug target identification. PLoS One, 5, el1764. 被引量:1
  • 10Zhang, B., Wang, X. and Li, S. (2013) An integrative platform ofTCM network pharmacology and its application on an herbal formula, QingLuo-Yin. Evid-Based Compl. Alt. Med., 2013, 456747. 被引量:1

同被引文献12

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部